1. Home
  2. GROY vs VALN Comparison

GROY vs VALN Comparison

Compare GROY & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GROY

Gold Royalty Corp.

HOLD

Current Price

$4.94

Market Cap

938.2M

Sector

N/A

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$9.87

Market Cap

855.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GROY
VALN
Founded
2020
2012
Country
Canada
France
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
938.2M
855.8M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
GROY
VALN
Price
$4.94
$9.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$5.15
$15.75
AVG Volume (30 Days)
3.0M
23.8K
Earning Date
11-05-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,464,000.00
$211,089,992.00
Revenue This Year
$72.11
$3.64
Revenue Next Year
$100.63
$12.23
P/E Ratio
N/A
N/A
Revenue Growth
86.30
13.48
52 Week Low
$1.20
$4.22
52 Week High
$5.05
$12.25

Technical Indicators

Market Signals
Indicator
GROY
VALN
Relative Strength Index (RSI) 75.93 62.96
Support Level $4.16 $9.85
Resistance Level $4.45 $10.37
Average True Range (ATR) 0.19 0.34
MACD 0.07 0.13
Stochastic Oscillator 90.54 87.83

Price Performance

Historical Comparison
GROY
VALN

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: